{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "KODK",
  "name": "Eastman Kodak Company",
  "url": "https://orbyd.app/dossiers/KODK/",
  "json_url": "https://orbyd.app/dossiers/KODK.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "Pension-reversion fat pitch fired and is spent; the re-rate has fully unwound from the $14.87 May high to ~$7.78, losing the $9 June shelf and printing a $4.94 52-week low. A July 1 resale shelf of up to ~39.46M shares and a June 29 Sell downgrade cap sentiment while the battery/pharma pivot (AM&C only +3% YoY) still has no signed offtake. Broken structure into an Aug 11 earnings binary — not a setup.",
  "invalidation_trigger": "A weekly close below $6.90 forfeits the rising 200-day / prior base and re-opens the $4.94 52-week low, confirming the re-rate is fully unwound; the Aug 11 Q2 print showing AM&C revenue flat or down sequentially with no named battery offtake would seal that the pivot has stalled.",
  "catalyst_date": "2026-08-11",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "cyclical-industrials",
    "solar-clean-energy",
    "precision-biotech-therapeutics",
    "m-and-a-special-situations"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Q2 2026 earnings confirmed 2026-08-11 — respect the 3-trading-day pre-print blackout (no fresh entries after ~2026-08-06 close).",
    "July 1, 2026 resale registration covers up to ~39.46M shares (plus 4.43M selling-holder shares) for secondary resale, no proceeds to the company — a live dilution/overhang risk; rallies likely met with supply until absorbed.",
    "$100M ATM shelf (filed Nov 2025) caps upside — any rip into $9+ likely met with issuance.",
    "Pension reversion COMPLETED 2025-12-02 ($1.023B freed, ~$767M reverted, term loan cut to $200M, net-cash, FY2025 cash $337M) — realized and in the price; do NOT frame as an upcoming catalyst.",
    "Do NOT average down — broken structure, not a value entry. Net-cash balance sheet does not offset a broken tape plus dilution overhang. Re-enter only on a fresh higher-low reclaim above the lost ~$9.20 shelf on volume.",
    "Battery/pharma pivot has product in pilots (Ateios RaiCore LCO/LFP/NMC, PFAS-free <20ppm, >98% loading; 4 pharma reagents added Jan 26 2026) but NO signed offtake as of the May 7 Q1 call — AM&C only +3% YoY. Demand a named offtake before treating the pivot as a live catalyst.",
    "Weiss Ratings downgraded to Sell (D+) on 2026-06-29 — sell-side sentiment negative; short interest ~5.6M shares means the squeeze leg is gone (no retail-squeeze dynamic).",
    "KODK correlation to rare-earth/battery peers weak (~0.35–0.45) — don't assume it joins any materials rally automatically; demand tape confirmation. True input-cost sensitivity is silver/aluminum (drove Q1 inventory build + margin pressure)."
  ],
  "body_markdown": "## Current Thesis\nThe fat pitch has already been paid, and the tape is now confirming it. Kodak's $1.023B KRIP pension reversion **completed December 2, 2025** — ~$767M reverted, the term loan cut to a $200M balance, FY2025 cash $337M (+$136M YoY), net-cash for the first time in a decade. That de-risking drove a ~$6 March base to a **$14.87 52-week high on May 4, 2026**. The move has since fully unwound: the stock corrected through the June $9.06 low, lost the $9.00 shelf the last read flagged, and trades **~$7.78 (July 16, 2026), down ~48% from the high**, with a fresh **$4.94 52-week low** now on the tape. Two July catalysts sealed the reversal — a **July 1 resale registration covering up to ~39.46M shares** (secondary; the company receives no proceeds, pure overhang) and a **June 29 Weiss Ratings downgrade to Sell (D+)**. What remains is an early, unsigned battery-electrode and pharma-reagent pivot inside Advanced Materials & Chemicals (AM&C revenue only +3% YoY in Q1) with no named offtake and a **binary Q2 print on August 11**. This is a broken structure under a dilution overhang heading into earnings — a value-trap dip, not an accelerating setup. Fresh entries here are a pass until it bases and reclaims.\n\n## Bull Case\n- **Balance sheet repaired, not narrated**: the Dec 2, 2025 reversion freed $1.023B; ~$767M reverted, the term loan cut to $200M, FY2025 cash $337M (+$136M YoY) against a $300M term loan + Series B preferred leaves the company net-cash. A Q1 $46M cash inflow from KRIP reversion investments (reported May 7, 2026) keeps that liquidity building.\n- **Operating inflection multiple quarters deep**: Q4 2025 (reported Mar 13, 2026) revenue $290M (+9%), operational EBITDA $22M (+144%); Q1 2026 (reported May 7, 2026) revenue $265M (+7% from $247M), gross margin 22% vs 19%, operational EBITDA $15M vs $2M.\n- **Pivot has product in pilots**: the March 23, 2026 Ateios/RaiCore expansion took the battery-electrode platform to LCO/LFP/NMC with third-party PFAS-free verification (<20ppm organic fluorine vs a 100ppm threshold), 4th-gen electrodes at >98% active-material loading, and OEM pilot programs;\n- **Legacy base still growing**: Print revenue $180M in Q1 2026 (+9% YoY) — the imaging core is funding the pivot rather than collapsing on the timeline bears modeled.\n- **Special-situation optionality**: a net-cash balance sheet makes an AM&C carve-out or strategic review more credible than at any point in the past decade.\n\n## Bear Case\n- **The binary already paid and the trend is spent**: reversion closed Dec 2, 2025, the re-rate topped at $14.87 on May 4, and the stock is now ~48% below that high with a $4.94 52-week low printed. Buying ~$7.78 is paying after the event for a second leg that needs a new, un-named catalyst.\n- **Fresh dilution overhang**: the July 1, 2026 resale registration covers up to ~39.46M shares (plus 4.43M selling-holder shares) for secondary resale with no proceeds to the company — a live supply cap that took the stock down ~10% on July 2 and will absorb rallies until cleared.\n- **Sell-side turned negative**: Weiss Ratings downgraded to Sell (D+) on June 29, 2026 citing deteriorating fundamentals — the opposite of the clustered-upgrade acceleration this playbook wants.\n- **GAAP deteriorating under the EBITDA gloss**: Q1 2026 GAAP net loss widened to $16M from $7M a year earlier even as operational EBITDA improved; Q1 cash fell $38M on a silver/aluminum-driven inventory build plus a $50M term-loan repayment.\n- **AM&C growth is the wrong slope**: AM&C revenue +3% YoY in Q1 2026 ($76M vs $74M), trailing Print's +9% and far short of a \"meaningful 2H-2026 offtake\" inflection; no named, signed battery offtake was disclosed on the May 7 call.\n- **The squeeze leg is gone**: short interest sits near ~5.6M shares — the retail-squeeze dynamic that amplified the April/May move is no longer present.\n\n## Setup & Price Structure\nThe structure is broken, not basing. Sequence: ~$6 March base → $12.48 (Apr 29) → $14.87 52-week high (May 4) → correction through the $9.06 June low → loss of the $9.00 shelf → a new $4.94 52-week low on the July dilution news → a partial recovery to ~$7.78 (July 16, prior close $8.06 July 15, day range $7.73–$8.04). Price sits below its declining short-term moving averages and near the rising 200-day / prior-base region around $7. This is the beginner-trap zone the playbook explicitly warns on: a \"cheap, net-cash\" name after a hard break invites averaging into a value trap, and a 5%-below-high bounce into a live 39.46M-share resale overhang is exactly the supply a fresh long gets sold into. There is no higher-low reclaim yet, no clustered upgrades, and no accelerating narrative — the tape is post-mania digestion at best and continuation lower at worst. Stand aside until a clean higher-low forms above the lost shelf on volume; do not chase or average down.\n\n## Catalyst Calendar (next 30 days)\n- **2026-08-11 (confirmed)** — Q2 2026 earnings. The binary: watch AM&C sequential revenue and any named/signed battery offtake, GAAP loss trajectory vs the $16M Q1 loss, and cash after the Q1 $38M draw. Respect a 3-trading-day pre-print blackout (no fresh entries after ~2026-08-06 close).\n- **Ongoing (not a dated event)** — the July 1, 2026 resale registration (up to ~39.46M shares) is a standing supply overhang; any rally is likely met with issuance until it is absorbed. The $100M ATM shelf (filed Nov 2025) caps upside on strength.\n- Nothing else scheduled inside 30 days; the Dec 2, 2025 pension reversion is realized and in the price — not an upcoming catalyst.\n\n## What Would Change Our Mind\n- A **reclaim of the lost ~$9.20 June shelf on above-average volume** with the resale overhang visibly absorbed would rebuild a fresh higher-low long setup worth a probe.\n- A **named, signed battery-electrode offtake** (Ateios/RaiCore with a disclosed OEM) or AM&C revenue re-accelerating to double-digit YoY on the Aug 11 print would convert the pivot from story to catalyst.\n- Clustered analyst upgrades reversing the June 29 Sell call, or a strategic-review/carve-out announcement leveraging the net-cash balance sheet, would restore the special-situation thesis.\n- Absent those, cheapness and a clean balance sheet are not a reason to buy a broken tape into a dilution shelf.\n\n## Correlation Notes\nKODK is an idiosyncratic special situation with low, unreliable correlation (~0.35–0.45) to rare-earth/battery-materials peers — do not assume it joins any materials or clean-energy rally automatically; demand tape confirmation before treating peer strength as a tell. Its true input-cost sensitivity is to silver and aluminum, which drove the Q1 inventory build and margin pressure, so commodity spikes are a margin headwind, not a narrative tailwind. Beta to the broad tape is muted relative to its own event calendar; the stock trades on filings (reversion 8-Ks, resale registrations) and the earnings print far more than on sector flow.",
  "first_seen": "2026-04-19",
  "last_analyzed": "2026-07-18T08:00:37+00:00",
  "last_synthesized": "2026-07-18",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}